Press Releases

Alere is leading the industry in informed, connected healthcare. Explore our news room to see how.

All
  • All
  • Corporate / Financial
  • Cardiometabolic
  • Connected Health
  • Health Information Solutions
  • Infectious Disease
  • Toxicology
  • Women's health
Date Press Release PDF
Dec 10
2014
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
Dec 09
2014
U.S. Food and Drug Administration Grants CLIA Waiver for Alere Determine™ HIV-1/2 Ag/Ab Combo Test
Dec 08
2014
Alere Initiates Voluntary URGENT CORRECTION for Use of Alere INRatio® and INRatio®2 PT/INR Monitor System
Nov 21
2014
Alere Appoints Juliet Cunningham to Lead Investor Relations
Nov 18
2014
Alere to Participate in Jefferies Global Healthcare Conference
Nov 14
2014
Malaria No More Honors Alere’s Contributions to Diagnosing and Eliminating Malaria in sub-Saharan Africa
Oct 28
2014
Alere Inc. Announces Q3 2014 Results
Oct 28
2014
Namal Nawana Named CEO and President of Alere Inc.
Oct 28
2014
Optum, Alere Health to Combine to Help Health Plans, Employers and States Improve Population Health, Reduce Health Care Costs
Oct 02
2014
Entamoeba histolytica Rapid Test Receives CE Mark
Oct 01
2014
Alere Awarded U.S. Government Contract to Advance Development of Point-of-Care Molecular Diagnostic for Pandemic Influenza
Sep 23
2014
Alere to Support Organisation of African First Ladies Against HIV/AIDS (OAFLA) in New Effort to End Mother-to-Child Transmission of HIV and Syphilis
Sep 19
2014
Alere Applauds President’s Executive Order Combating Antibiotic-Resistant Bacteria
Sep 15
2014
Alere Responds to Letter from Former Executives
Sep 02
2014
Alere Inc. Declares Cash Dividend on Its Series B Convertible Perpetual Preferred Stock
Aug 08
2014
Alere to Attend Canaccord Genuity Conference
Aug 04
2014
Alere Inc. Announces Q2 2014 Results
Jul 21
2014
Alere Earns Ethical and Quality Certification for Educational Anticoagulation Website
Jul 14
2014
New Alere™ q Point-of-Care Early Infant Diagnosis Test Prototype Accurately Detects HIV in Infants with High Sensitivity and Specificity in Primary Health Clinics in Mozambique
Jul 01
2014
Alere Announces Management Transition
Jun 26
2014
Alere Supports National HIV Testing Day
Jun 18
2014
Alere Opts Not to Pursue Initial Public Offering by BBI Diagnostics Group plc
Jun 16
2014
Alere Receives FDA Clearance for Alere™ i Influenza A and B Test
Jun 05
2014
Alere Inc. Secures Important Permissions for Previously Announced Transaction Involving BBI Diagnostics Group plc
May 22
2014
Alere to Attend Upcoming Healthcare Conferences
May 21
2014
Alere Inc. Announces Commencement of Consent Solicitation Related to its 7.250% Senior Notes due 2018, 8.625% Senior Subordinated Notes due 2018 and 6.500% Senior Subordinated Notes due 2020.
May 15
2014
Alere Inc. Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock
May 06
2014
Alere Initiates Voluntary URGENT PRODUCT RECALL of Alere INRatio®2 PT/INR Professional Test Strips
May 05
2014
Alere Announces Separation of Chief Executive Officer and Chairman Roles and Review of Strategy
Apr 29
2014
Alere Inc. Announces Q1 2014 Results
Apr 29
2014
Alere Inc. Announces Plan for Initial Public Offering by BBI Diagnostics Group plc
Apr 25
2014
Alere and Malaria No More Provide One Million Rapid Malaria Tests to Children in Zambia
Apr 22
2014
Alere Inc. Schedules Conference Call for 8:30 a.m. ET April 29, 2014 to Discuss First Quarter 2014 Results
Mar 24
2014
Weekly Coagulation Self-testing among Warfarin Patients Significantly Improves Outcomes, According to Study Published in the American Journal of Managed Care
Mar 04
2014
Coagulation Home Testing Improves Outcomes among Atrial Fibrillation Patients on Warfarin Therapy and Enhances Clinical Efficiency, According to New Study
Mar 03
2014
Alere Inc. Declares Cash Dividend On Its Series B Convertible Perpetual Preferred Stock
Feb 24
2014
Alere to Attend Upcoming Financial Conferences
Feb 19
2014
Alere to Showcase Its Connected Health Technologies at HIMSS 2014
Feb 06
2014
Alere Inc. Announces Q4 2013 Results
Jan 30
2014
Alere Inc. Schedules Conference Call for 8:30 a.m. ET February 6, 2014 to Discuss Fourth Quarter 2013 Results
Jan 28
2014
Low-Intensity Weight Loss Program Targeting Obesity Leads to Clinically Significant & Sustainable Weight Loss
Jan 23
2014
First Rapid Molecular Diagnostic Test to Detect Influenza A and B Virus in Under 15 Minutes Now Available in Europe on the Alere i Platform
Jan 14
2014
Alere HomeLink Receives FDA Clearance for Over-the-Counter Use

Be Alerted

Stay alerted about our latest news and announcements

Sign Up

©2010-2015 Alere. All rights reserved. The Alere Logo and Alere are trademarks of the Alere group of companies. All other trademarks referenced are trademarks of their respective owners. This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Alere takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage. Your use of this website and the information contained herein is subject to our Website Terms and Conditions and Privacy Policy. Photos displayed are for illustrative purposes only. Any person depicted in such photographs is a model.